Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-010796

Chief Financial Officer sold 15,000 shares at $85.45 ($1,281,750)

  • Chief Financial Officer acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gordon Stephen · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-01 Exercise or conversion : show line 1 in the form 10b5-1 +8,833 $13.28 $117,302 21,908 D
2024-02-01 Exercise or conversion : show line 2 in the form 10b5-1 +3,644 $16.14 $58,814 25,552 D
2024-02-01 Exercise or conversion : show line 3 in the form 10b5-1 +2,523 $38.46 $97,035 28,075 D
2024-02-01 Sale : show line 4 in the form 10b5-1 −15,000 $85.45 $1,281,750 13,075 D
Open-market sales · 15,000 sh · avg $85.45 · $1,281,750

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-02-01 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −8,833 28,167 D
2024-02-01 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −3,644 2,084 D
2024-02-01 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −2,523 67,477 D
Loading xslF345X05/ownership.xml…